European Vaccine Initiative: lessons from developing malaria vaccines

Protective efficacy of malaria case management and intermittent preventive treatment for preventing malaria mortality in children: a systematic review for the Lives Saved Tool

(2011) Julie Thwing et al.   BMC PUBLIC HEALTH

The RTS,S vaccine candidate for malaria

(2011) Jason A Regules et al.   Expert Review of Vaccines

The mysteries of immunity to malaria

(2011) Brian Greenwood et al.   LANCET

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

(2011) Ally Olotu et al.   LANCET INFECTIOUS DISEASES

Comparative decline in funding of European Commission malaria vaccine projects: what next for the European scientists working in this field?

(2011) Regitze L Thøgersen et al.   MALARIA JOURNAL

Protection against Malaria by MSP3 Candidate Vaccine

(2011) Sodiomon B. Sirima et al.   NEW ENGLAND JOURNAL OF MEDICINE

Live Attenuated Malaria Vaccine Designed to Protect Through Hepatic CD8+ T Cell Immunity

(2011) J. E. Epstein et al.   SCIENCE

Addressing the needs and gaps in safety assessment of vaccines during clinical trials in resource limited countries

(2011) Agnes Kisser et al.   VACCINE

A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine

(2011) David W. Porter et al.   VACCINE

Towards validated assays for key immunological outcomes in malaria vaccine development

(2011) David R. Cavanagh et al.   VACCINE

Malaria vaccine candidate: Design of a multivalent subunit α-helical coiled coil poly-epitope

(2011) Sope Olugbile et al.   VACCINE

A Research Agenda for Malaria Eradication: Vaccines

(2011)   PLOS MEDICINE

Association between Naturally Acquired Antibodies to Erythrocyte‐Binding Antigens ofPlasmodium falciparumand Protection from Malaria and High‐Density Parasitemia

(2010) Jack S. Richards et al.   CLINICAL INFECTIOUS DISEASES

Genetically engineered, attenuated whole-cell vaccine approaches for malaria

(2010) Ashley Vaughan et al.   Human vaccines & immunotherapeutics

European malaria vaccine initiative: Portfolio and perspectives for the future

(2010) Egeruan Babatunde Imoukhuede et al.   Human vaccines & immunotherapeutics

From the circumsporozoite protein to the RTS,S/AS candidate vaccine

(2010) Joe Cohen et al.   Human vaccines & immunotherapeutics

Prime-boost vectored malaria vaccines: Progress and prospects

(2010) Adrian V. S. Hill et al.   Human vaccines & immunotherapeutics

Allelic Diversity and Naturally Acquired Allele-Specific Antibody Responses to Plasmodium falciparum Apical Membrane Antigen 1 in Kenya

(2010) F. H. A. Osier et al.   INFECTION AND IMMUNITY

Advances and challenges in malaria vaccine development

(2010) Peter D. Crompton et al.   JOURNAL OF CLINICAL INVESTIGATION

Reducing empiricism in malaria vaccine design

(2010) Vasee S Moorthy et al.   LANCET INFECTIOUS DISEASES

Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine

(2010) Amed Ouattara et al.   MALARIA JOURNAL

Estimates of the burden of malaria morbidity in Africa in children under the age of 5 years

(2010) Arantxa Roca-Feltrer et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Safety and immunogenicity of the malaria vaccine candidate GMZ2 in malaria-exposed, adult individuals from Lambaréné, Gabon

(2010) Benjamin Mordmüller et al.   VACCINE

Acquired Immunity to Malaria

(2009) D. L. Doolan et al.   CLINICAL MICROBIOLOGY REVIEWS

Rescuing the bottom billion through control of neglected tropical diseases

(2009) Peter J Hotez et al.   LANCET

Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data

(2009) Vasee S Moorthy et al.   MALARIA JOURNAL

Protection against a Malaria Challenge by Sporozoite Inoculation

(2009) Meta Roestenberg et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children

(2009) Sodiomon B. Sirima et al.   PLoS One

Malaria vaccines – how and when to proceed?

(2009) Alister G. Craig et al.   TRENDS IN PARASITOLOGY

Safety and immunogenicity of GMZ2 — a MSP3–GLURP fusion protein malaria vaccine candidate

(2009) Meral Esen et al.   VACCINE

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors againstPlasmodium berghei

(2008) Arturo Reyes-Sandoval et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya

(2008) Wendy P O'Meara et al.   LANCET

Safety and Immunogenicity of a Recombinant Plasmodium falciparum AMA1 Malaria Vaccine Adjuvanted with Alhydrogel™, Montanide ISA 720 or AS02

(2008) Meta Roestenberg et al.   PLoS One

Apical membrane antigen 1: a malaria vaccine candidate in review

(2008) Edmond J. Remarque et al.   TRENDS IN PARASITOLOGY